Trident Lifeline Ltd (543616) — Announcement | 8 September 2026
Trident Lifeline Limited received the PHARMEXCIL award for outstanding pharmaceutical exports during 2024-25, presented on September 7, 2026, in New Delhi, recognizing its role in advancing India's global pharmaceutical presence and commitment to industry growth.
About Trident Lifeline Ltd (543616)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when 543616 files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track 543616 — Free💡 Ask AI about this filing
📊 More 543616 filings
- Announcement — 30 September 2026Trident Lifeline Ltd announced the closure of its trading window effective September 29, 2026, until...
- 🔴 Corporate Action — 30 September 2026Trident Lifeline announced on September 30, 2026, that it acquired an additional 1.00% equity stake ...
- 🟡 Board Meeting — 29 September 2026Trident Lifeline Ltd announced a board meeting on October 5, 2026 to evaluate raising funds via warr...
- 🟡 Voting Results — 28 September 2026At the 13th AGM on September 26, 2026, shareholders approved all five resolutions including the audi...
- 🔴 Announcement — 28 September 2026Trident Lifeline Ltd announced a scheduled one-on-one plant visit with Stylus Holdings on September ...
🔥 Also filed on 8 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day